Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R2 | Q9NPC1 | 3/20 | 0.33 |
| ▸ | AGTR1 | P30556 | 7/20 | 0.32 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.31 |
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7280315 | 0.91 | LTB4R2 (0.37) | LTB4R2AGTR1AGTR2CNR2ABCB11 | |
| SCHEMBL2530 | 0.85 | AGTR1 (0.44) | LTB4R2AGTR1AGTR2ABCB11GP6 | |
| SCHEMBL2568 | 0.83 | AGTR1 (0.39) | LTB4R2AGTR1AGTR2ABCB11GP6 | |
| SCHEMBL7271922 | 0.76 | AGTR1 (0.49) | LTB4R2AGTR1AGTR2ABCB11GP6 | |
| SCHEMBL2674 | 0.73 | AGTR1 (0.38) | LTB4R2AGTR1AGTR2ABCB11GP6 | |
| SCHEMBL2291 | 0.73 | LTB4R2 (0.35) | LTB4R2AGTR1AGTR2ABCB11GP6 | |
| SCHEMBL2874 | 0.72 | AGTR1 (0.52) | LTB4R2AGTR1ABCB11GP6 | |
| SCHEMBL2875 | 0.72 | AGTR1 (0.52) | LTB4R2AGTR1ABCB11GP6 | |
| SCHEMBL3100 | 0.71 | AGTR1 (0.46) | LTB4R2AGTR1AGTR2ABCB11GP6 | |
| SCHEMBL7279125 | 0.70 | AGTR1 (0.39) | LTB4R2AGTR1AGTR2ABCB11GP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5399578-A | Hypotensive; valsartan; high blood pressure and cardiac insufficiency | CIBA-GEIGY CORP (US) | 1995-03-21 | — | — | US | disclosed |